Analyst Viewpoint
Rise in prevalence of neurological disorders such as Parkinson's disease, epilepsy, Alzheimer's disease, and movement disorders are driving the global brain implants industry. Brain implants are electronic devices implanted into the brain to provide therapeutic or prosthetic functions. Increase in geriatric population is another major factor propelling market expansion. Furthermore, surge in healthcare expenditure, rise in investments in healthcare infrastructure, and increase in awareness about neurological conditions & available treatments are expected to bolster the global brain implants market size during the forecast period.
Integration of neuroprosthetics and brain-computer interfaces offers lucrative opportunities to brain implants market players. Companies are focusing on refining brain implants in order to provide more efficient treatments, better patient outcomes, and improved quality of life.
Brain implants include medical devices created to interact with the brain's neural networks for therapeutic reasons. These are commonly termed as neural implants or neurostimulation devices.
These devices consist of deep brain stimulation (DBS) devices, spinal cord stimulators, and responsive neurostimulation (RNS) systems. These work by adjusting electrical signals within the brain or nervous system to alleviate symptoms linked to neurological disorders such as Parkinson's disease, epilepsy, chronic pain, and movement disorders.
Recent advancements in brain implants have concentrated on improving device accuracy, functionality, and patient results. Innovations encompass closed-loop systems capable of detecting and responding to real-time neural activity, offering tailored treatment.
Enhancements in device connectivity, size reduction, and battery life have increased patient comfort and broadened treatment choices. These advancements demonstrate the market's progression toward more efficient, less invasive, and patient-focused neurological therapies. These factors are likely to augment the global brain implants market demand.
Increase in individuals affected by neurological conditions such as Parkinson's disease, epilepsy, Alzheimer's disease, and various movement disorders is a significant driver of the global brain implants industry. These conditions cause severe symptoms that disrupt daily life.
As conventional treatments may have limitations in effectively managing these symptoms, there is a growing interest in innovative solutions such as brain implants. For instance, in 2021, nearly 5.8 million people in the U.S. lived with Alzheimer's dementia, a number projected to escalate to 14.3 million by 2060 (Alzheimer's Association, 2022). Similar trends are observed for other debilitating conditions, with over 1 million Americans affected by Parkinson's and 5.1 million by epilepsy.
Brain implants, also known as neural implants or neurostimulation devices, present promising avenues for therapy. These directly engage with the brain's neural circuits, modulating electrical signals to either stimulate or suppress specific brain activities.
For instance, deep brain stimulation (DBS) implants have demonstrated effectiveness in alleviating symptoms of Parkinson's disease and essential tremors by delivering electrical impulses to precise brain areas.
Limitations of conventional pharmaceutical methods in effectively managing neurological disorders is also boosting demand for brain implants. Patients and healthcare providers seek alternative approaches that promise better symptom control, improved quality of life, and reduced reliance on medications known to cause unwanted side effects.
Advancements in healthcare, life sciences, and improved public health measures have extended the average lifespan of elderly individuals across the globe. This increases age-related neurological conditions among older adults, including Parkinson's disease, Alzheimer's disease, and other cognitive disorders. These conditions often lead to cognitive decline, movement difficulties, and other challenging symptoms that impact the well-being of older individuals.
In the past few years, around 524 million individuals, constituting 8% of the global population, were aged 65 and above. Projections from the National Institute on Aging suggest that by 2050, the number would rise to around 1.5 billion, accounting for nearly 16% of the world's population, with much of this growth expected in developing nations.
Several developing countries in Asia Pacific and South America are anticipated to witness a threefold increase in the geriatric population in the next decade. As individuals age, the likelihood of developing neurological disorders also increases. Presently, approximately 1% of people aged 60 or above globally are estimated to have Parkinson's disease, but this rate jumps to 5% among those aged 85 and older.
In terms of product type, the spinal cord stimulator segment accounted for the largest global brain implants market share in 2022. This is ascribed to broad application range, established track record, and ongoing advancements.
Companies such as Nevro are integrating AI into their spinal cord stimulator systems, enabling real-time adjustments based on individual pain patterns and optimizing pain relief while potentially minimizing side effects.
Based on application, the chronic pain segment is expected to grow at a rapid pace during the forecast period. Chronic pain is a global epidemic, affecting over 500 million people worldwide. The sheer number creates significant demand for effective treatment solutions.
Existing treatments for chronic pain often fall short, offering inadequate relief or carrying unwanted side effects. Brain implants, such as spinal cord stimulators (SCS), offer hope with their non-invasive nature and promising pain reduction. The race for innovative pain management solutions is on, and brain implants are poised to play a leading role in offering millions a life free from chronic pain's grip.
In terms of end-user, the hospitals segment to anticipated to dominate the global brain implants market during the forecast period. Hospitals offer a complete package, from pre-operative consultations and surgery to post-operative monitoring and rehabilitation, streamlining the brain implant journey for patients.
Hospitals continuously invest in cutting-edge equipment and technology, such as MRI-compatible DBS systems and robotic arms for precise implant placement, making them desirable destinations for patients seeking advanced options. Remote consultations and monitoring facilitate patient access to specialist care, potentially expanding the reach of brain implant surgeries beyond major center.
As per brain implants market analysis, North America accounted for the largest share in 2022. This is ascribed to combination of advanced technology, favorable healthcare factors, and supportive environment for research and development in the region.
North America is a hub for cutting-edge brain implant solutions, offering hope to millions suffering from neurological disorders. Leading universities and private companies in the region are investing in brain implant research, leading to technological advancements such as AI-powered simulation algorithms and new application explorations for chronic pain and other conditions.
European countries, with their established public healthcare systems and emphasis on universal access, often provide coverage for brain implant procedures, increasing affordability for patients. This fosters a larger market compared to regions with limited healthcare access.
In November 2023, the EU Commission announced a EUR 1 Bn investment in the Human Brain Project 2, focusing on advancing the understanding of the brain and developing new technologies for treating neurological disorders, potentially benefiting the development of future brain implants.
According to brain implants market forecast, Asia Pacific is likely to witness rapid growth during the forecast period. The region's large population, increasing healthcare accessibility, and focus on technological advancements position it to play a major role in shaping this transformative field.
The global brain implants market is fragmented, with the presence of large number of players. Manufacturers are adopting strategies such as investment in R&D and collaborations in order to increase market presence.
Medtronic, Abbott, Boston Scientific Corporation, NeuroPace, Renishaw plc, LivaNova plc, and Nevro Corp. are the prominent players in the brain implants market.
Key players in the brain implants market report have been profiled based on parameters such as company overview, latest developments, business strategies, application portfolio, business segments, and financial overview.
| Attribute | Detail |
|---|---|
| Size in 2022 | US$ 4.2 Bn |
| Forecast Value in 2031 | More than US$ 8.8 Bn |
| Growth Rate (CAGR) | 8.4% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 4.2 Bn in 2022
It is projected to reach more than US$ 8.8 Bn by 2031
The CAGR is anticipated to be 8.4% from 2023 to 2031
North America is expected to account for the largest share from 2023 to 2031
Medtronic, Abbott, Boston Scientific Corporation, NeuroPace, Renishaw plc, LivaNova plc, and Nevro Corp.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Brain Implants Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Brain Implants Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. egulatory Scenario
5.2. Prevalence and Incidence rate of various Neurological Disorders
5.3. Technological Advancements
6. Global Brain Implants Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Deep Brain Stimulator
6.3.2. Vagus Nerve Stimulator
6.3.3. Spinal Cord Stimulator
6.4. Market Attractiveness Analysis, by Product Type
7. Global Brain Implants Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Chronic Pain
7.3.2. Parkinson’s Disease
7.3.3. Essential Tremor
7.3.4. Epilepsy
7.3.5. Depression
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Brain Implants Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Brain Implants Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Brain Implants Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Deep Brain Stimulator
10.2.2. Vagus Nerve Stimulator
10.2.3. Spinal Cord Stimulator
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Chronic Pain
10.3.2. Parkinson’s Disease
10.3.3. Essential Tremor
10.3.4. Epilepsy
10.3.5. Depression
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Brain Implants Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Deep Brain Stimulator
11.2.2. Vagus Nerve Stimulator
11.2.3. Spinal Cord Stimulator
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Chronic Pain
11.3.2. Parkinson’s Disease
11.3.3. Essential Tremor
11.3.4. Epilepsy
11.3.5. Depression
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Brain Implants Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Deep Brain Stimulator
12.2.2. Vagus Nerve Stimulator
12.2.3. Spinal Cord Stimulator
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Chronic Pain
12.3.2. Parkinson’s Disease
12.3.3. Essential Tremor
12.3.4. Epilepsy
12.3.5. Depression
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of APAC
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Brain Implants Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Deep Brain Stimulator
13.2.2. Vagus Nerve Stimulator
13.2.3. Spinal Cord Stimulator
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Chronic Pain
13.3.2. Parkinson’s Disease
13.3.3. Essential Tremor
13.3.4. Epilepsy
13.3.5. Depression
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. rest of LATAM
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Brain Implants Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Deep Brain Stimulator
14.2.2. Vagus Nerve Stimulator
14.2.3. Spinal Cord Stimulator
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Chronic Pain
14.3.2. Parkinson’s Disease
14.3.3. Essential Tremor
14.3.4. Epilepsy
14.3.5. Depression
14.3.6. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Medtronic
15.2.1.1. Company Overview
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Business Strategies
15.2.1.5. Recent Developments
15.2.2. Abbott
15.2.2.1. Company Overview
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Business Strategies
15.2.2.5. Recent Developments
15.2.3. Boston Scientific Corporation
15.2.3.1. Company Overview
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Business Strategies
15.2.3.5. Recent Developments
15.2.4. NeuroPace
15.2.4.1. Company Overview
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Business Strategies
15.2.4.5. Recent Developments
15.2.5. Renishaw plc
15.2.5.1. Company Overview
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Business Strategies
15.2.5.5. Recent Developments
15.2.6. LivaNova plc
15.2.6.1. Company Overview
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Business Strategies
15.2.6.5. Recent Developments
15.2.7. Nevro Corp.
15.2.7.1. Company Overview
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Business Strategies
15.2.7.5. Recent Developments
List of Tables
Table 01: Global Brain Implants Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Brain Implants Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Brain Implants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Brain Implants Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Brain Implants Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 06: North America Brain Implants Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 07: North America Brain Implants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: North America Brain Implants Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 09: Europe Brain Implants Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 10: Europe Brain Implants Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 11: Europe Brain Implants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Europe Brain Implants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Asia Pacific Brain Implants Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 14: Asia Pacific Brain Implants Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Asia Pacific Brain Implants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Brain Implants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Latin America Brain Implants Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Latin America Brain Implants Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 19: Latin America Brain Implants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Latin America Brain Implants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Middle East & Africa Brain Implants Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 22: Middle East & Africa Brain Implants Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Middle East & Africa Brain Implants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 24: Middle East & Africa Brain Implants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Brain Implants Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Brain Implants Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 03: Global Brain Implants Market Value Share Analysis, by Deep Brain Stimulator, 2022 and 2031
Figure 04: Global Brain Implants Market Value Share Analysis, by Vagus Nerve Stimulator, 2022 and 2031
Figure 05: Global Brain Implants Market Value Share Analysis, by Spinal Cord Stimulator, 2022 and 2031
Figure 06: Global Brain Implants Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 07: Global Brain Implants Market Value Share Analysis, by Application 2022 and 2031
Figure 08: Global Brain Implants Market Value Share Analysis, by Chronic Pain, 2022 and 2031
Figure 09: Global Brain Implants Market Value Share Analysis, by Parkinson’s Disease, 2022 and 2031
Figure 10: Global Brain Implants Market Value Share Analysis, by Essential Tremor, 2022 and 2031
Figure 11: Global Brain Implants Market Value Share Analysis, by Epilepsy, 2022 and 2031
Figure 12: Global Brain Implants Market Value Share Analysis, by Depression, 2022 and 2031
Figure 13: Global Brain Implants Market Value Share Analysis, by Others, 2022 and 2031
Figure 14: Global Brain Implants Market Attractiveness Analysis, by Application, 2023–2031
Figure 15: Global Brain Implants Market Value Share Analysis, by End-user, 2022 and 2031
Figure 16: Global Brain Implants Market Value Share Analysis, by Hospitals, 2022 and 2031
Figure 17: Global Brain Implants Market Value Share Analysis, by Specialty Centers, 2022 and 2031
Figure 18: Global Brain Implants Market Value Share Analysis, by Others, 2022 and 2031
Figure 19: Global Brain Implants Market Attractiveness Analysis, by End-user, 2023–2031
Figure 20: Global Brain Implants Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Brain Implants Market Attractiveness Analysis, by Region, 2023–2031
Figure 22: North America Brain Implants Market Value (US$ Mn) Forecast, 2017–2031
Figure 23: North America Brain Implants Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 24: North America Brain Implants Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 25: North America Brain Implants Market Value Share Analysis, by Application, 2022 and 2031
Figure 26: North America Brain Implants Market Attractiveness Analysis, by Application, 2023–2031
Figure 27: North America Brain Implants Market Value Share Analysis, by End-user, 2022 and 2031
Figure 28: North America Brain Implants Market Attractiveness Analysis, by End-user, 2023–2031
Figure 29: North America Brain Implants Market Value Share Analysis, by Country, 2022 and 2031
Figure 30: North America Brain Implants Market Attractiveness Analysis, by Country, 2023–2031
Figure 31: Europe Brain Implants Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: Europe Brain Implants Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 33: Europe Brain Implants Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 34: Europe Brain Implants Market Value Share Analysis, by Application, 2022 and 2031
Figure 35: Europe Brain Implants Market Attractiveness Analysis, by Application, 2023–2031
Figure 36: Europe Brain Implants Market Value Share Analysis, by End-user, 2022 and 2031
Figure 37: Europe Brain Implants Market Attractiveness Analysis, by End-user, 2023–2031
Figure 38: Europe Brain Implants Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 39: Europe Brain Implants Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 40: Asia Pacific Brain Implants Market Value (US$ Mn) Forecast, 2017–2031
Figure 41: Asia Pacific Brain Implants Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 42: Asia Pacific Brain Implants Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 43: Asia Pacific Brain Implants Market Value Share Analysis, by Application 2022 and 2031
Figure 44: Asia Pacific Brain Implants Market Attractiveness Analysis, by Application, 2023–2031
Figure 45: Asia Pacific Brain Implants Market Value Share Analysis, by End-user, 2022 and 2031
Figure 46: Asia Pacific Brain Implants Market Attractiveness Analysis, by End-user, 2023–2031
Figure 47: Asia Pacific Brain Implants Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 48: Asia Pacific Brain Implants Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 49: Latin America Brain Implants Market Value (US$ Mn) Forecast, 2017–2031
Figure 50: Latin America Brain Implants Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 51: Latin America Brain Implants Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 52: Latin America Brain Implants Market Value Share Analysis, by Application, 2022 and 2031
Figure 53: Latin America Brain Implants Market Attractiveness Analysis, by Application, 2023–2031
Figure 54: Latin America Brain Implants Market Value Share Analysis, by End-user, 2022 and 2031
Figure 55: Latin America Brain Implants Market Attractiveness Analysis, by End-user, 2023–2031
Figure 56: Latin America Brain Implants Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 57: Latin America Brain Implants Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 58: Middle East & Africa Brain Implants Market Value (US$ Mn) Forecast, 2017–2031
Figure 59: Middle East & Africa Brain Implants Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 60: Middle East & Africa Brain Implants Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 61: Middle East & Africa Brain Implants Market Value Share Analysis, by Application, 2022 and 2031
Figure 62: Middle East & Africa Brain Implants Market Attractiveness Analysis, by Application, 2023–2031
Figure 63: Middle East & Africa Brain Implants Market Value Share Analysis, by End-user, 2022 and 2031
Figure 64: Middle East & Africa Brain Implants Market Attractiveness Analysis, by End-user, 2023–2031
Figure 65: Middle East & Africa Brain Implants Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 66: Middle East & Africa Brain Implants Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 67: Global Brain Implants Market Share Analysis, by Company, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Brain Implants Market
